Many xenobiotics have been associated with endocrine effects in a wide range of biological systems. These associations are usually between small nonsteroid molecules and steroid receptor signaling systems. In this report, triclocarban (TCC; 3,4,4-trichlorocarbanilide), a common ingredient in personal care products that is used as an antimicrobial agent was evaluated and found to represent a new category of endocrinedisrupting substance. A cell-based androgen receptor-mediated bioassay was used to demonstrate that TCC and other urea compounds with a similar structure, which have little or no endocrine activity when tested alone, act to enhance testosterone (T)-induced androgen receptor-mediated transcriptional activity in vitro. This amplification effect of TCC was also apparent in vivo when 0.25% TCC was added to the diet of castrated male rats that were supported by exogenous testosterone treatment for 10 d. All male sex accessory organs increased significantly in size after the T؉TCC treatment, compared with T or TCC treatments alone. The data presented here suggest that the bioactivity of endogenous hormones may be amplified by exposure to commercial personal care products containing sufficient levels of TCC.
A N INCREASING NUMBER of experimental and epidemiological studies demonstrate that a variety of exogenous compounds, designated as endocrine-disrupting substances (EDS), have the ability to alter the signaling and function of endogenous hormones (1) (2) (3) . Reports have revealed associations between EDS exposures and reduced fecundity and fertility (1, 4) , abnormal fetal development (5) , timing of the onset of puberty (6, 7) , altered steroid hormone biosynthesis (8) , disruption of ovarian function (9, 10) , abnormal lactation (11) , early onset of reproductive senescence (1) , and cancer (12) (13) (14) . Whereas it remains a topic of debate, it is often speculated that exposures to persistent contaminants and lifestyle choices are key determinants in the pathogenesis of certain specific forms of developmental defects and reproductive failure with EDS being a principal contributor (3, 15) .
The increase of EDS exposures in daily life has raised public concern relating to their potential ecological and human health impacts. Efforts to identify and characterize EDS have revealed that a relatively large number of them have estrogenic, antiestrogenic, or antiandrogenic activity (16) . In contrast, comparatively few EDS have been associated with androgenic activity despite increasing public concern regarding the influence of environmental factors on male reproductive health (17, 18) . Triclocarban (TCC; 3,4,4Ј-trichlorocarbanilide), an antimicrobial compound, is commonly added to a wide range of household and personal care products including bar soaps, detergents, body washes, cleansing lotions, and wipes for its sanitizing properties (19) . TCCcontaining products have been marketed broadly for more than 45 yr and thus have a long history of use in Europe and the United States. It is estimated that approximately 1 million pounds of TCC are produced for the U.S. market per year, and recent reports suggest widespread TCC contamination of U.S. water resources (19) . Available research data on TCC's potential impact on reproductive health, however, are scarce and outdated, having been collected approximately 20 yr ago at a time when little attention was devoted to the influence of EDS in disturbances of hormonal homeostasis (20) . In this report, we show that TCC does not compete with the endogenous hormone for receptor binding but amplifies the androgen receptor-mediated, native androgen-induced transcriptional activity in vitro and in vivo. Thus, TCC should be considered as a new type of EDS (21) .
Materials and Methods

Chemicals and cell culture reagents
from Steraloids (Newport, RI). MDA-kb2, a cell line expressing endogenous androgen receptor (AR) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from American Type Culture Collection (Manassas, VA). The T and dihydrotestosterone were dissolved in absolute ethyl alcohol, and all other compounds were dissolved in dimethylsulfoxide. Phenol-red-free DMEM, L-15 (Leibovitz) medium, fetal bovine serum (FBS), l-glutamine, penicillin/streptomycin sulfate, blasticidin, and geneticin sulfate (G418) were obtained from Invitrogen (Carlsbad, CA). Dextran-coated charcoal-treated FBS was purchased from Hyclone (Logan, UT). Cell lysis buffer was purchased from Promega (Madison, WI). AR (441) mouse monoclonal IgG raised against human AR amino acids 299 -315 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Human chorionic gonadotropin (CG) standard (CR 121) was provided by Dr. John O'Connor (Columbia University, NY) and diluted in DMEM.
Cell-based human AR-mediated bioassay
A full detailed description of the development and application of the cell-based human AR-mediated bioassay has been published by Chen et al. (24) . Briefly, the bioassay system uses human embryonic kidney 293 cells that lack critical steroid metabolizing enzymes. The cells are stably transfected with PCDNA6-human AR and an MMTV-Luc.neo plasmid containing a luciferase reporting gene (24) . The cells (designated as 2933Y) are highly responsive to endogenous steroids as well as synthetic compounds. The signal induction is stable for more than 60 passages under double antibiotic selection conditions (24) .
The details of the in vitro procedures to evaluate the androgenic/ antiandrogenic activity of the EDS as well as the concentration selection for T in the AR-mediated cell system have been previously described (25) . The lower limit of detection of this assay is 15 pm T in cell culture medium (blank ϩ 3 sd) with intra-and interassay coefficients of variation of 7.4 and 7.5% at 0.25 nm T and 4.9 and 6.4% at 0.03 nm T, respectively (24) .
AR competitor assay
The competition of TCC with endogenous hormone for AR binding was evaluated using the PolarScreen AR fluorescence polarization (FP) assay with a Beacon 2000 fluorescence polarization system according to the manufacturer's instructions (Invitrogen; catalog no. P3018).
Western blot analysis
The expression of AR protein in MDA-kb2 and 2933Y cells was analyzed by Western blot. Briefly, after treatment with T (1.0 nm), TCC (1.0 m), or T and TCC in combination for 48 h, the cells were lysed, and whole-cell lysates were prepared and subjected to 7.5% SDS-PAGE and transferred to a polyvinylidene difluoride membrane. The membrane was then blocked in 20 mm Tris-HCl, 137 mm NaCl, and 0.1% (vol/vol) Tween 20 (pH 7.4) containing 5% nonfat milk. The membrane was immunoblotted with AR (441) mouse antihuman monoclonal antibody overnight, followed by secondary antibody (donkey antimouse antibody) coupled to horseradish peroxidase from Amersham Biosciences (Piscataway, NJ) for 1 h. The membrane was exposed on x-ray film (Eastman Kodak Co., Rochester, NY) using enhanced chemiluminescence Western blot detection reagents (Amersham Biosciences). To reprobe with ␤-actin, the membrane was stripped in stripping buffer at 53 C for 30 min.
cAMP/protein kinase A (PKA)-mediated luciferase transcriptional activity
Luciferase transcriptional activity mediated by the cAMP/PKA pathway was measured by the in vitro bioassay described by Jia et al. (26) and modified as described below. This assay uses human embryonic kidney 293 cells stably transfected with the human luteinizing/chorionic gonadotropin receptor gene and the luciferase reporter gene (pCRE-luc) (JK293) (27) . JK293 cells were cultured in DMEM containing 10% FBS, 2 mm l-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin sulfate, and 100 g/ml geneticin sulfate. After the JK293 cells were cultured to 80 -100% confluence in 100-ϫ 20-mm cell culture dishes, cells were counted and incubated in 96-well plates. (25) .
To compensate for any organic solvent effects, the final content of ethyl alcohol in both the AR-mediated and cAMP/PKA-mediated assay systems was 0.1% (vol/vol) for all studies, and the total DMSO concentration in the final culture media was no more than 0.2% (vol/vol). The total concentration of organic solvent (vol/vol) was maintained at the same level for both controls and test compounds.
MTT assay
The MTT assay for cell proliferation or cytotoxicity testing under varying concentrations of test compounds was performed according to the manufacturer's instructions (American Type Culture Collection; catalog no. 30-1010K) and has been described previously (25) . 
In vivo effect of TCC on accessory sex organ weight
Statistical analysis
For in vitro studies, the values shown are mean Ϯ sd from three independent experiments for each dose tested, and for the in vivo study, the values shown are mean Ϯ sd of each group. For both in vitro and in vivo data, one-way ANOVA was applied followed by multiple comparisons test when appropriate, using SigmaStat (Systat Software, San Jose, CA). The level of significance was set at P Ͻ 0.05. For the in vitro study, treatments were compared with the negative control group containing vehicle only to test for agonist properties, and for androgen antagonist properties, treatments were compared with the T-positive control group.
Results
Effect of TCC on cell proliferation and cytotoxicity
The structure of TCC is shown in did not result in cytotoxicity in 2933Y cells when tested alone or in combination with 0.125 nm of T (Fig. 2 ). Vehicle-treated or TCC-treated cells did not demonstrate statistically significant differences with respect to proliferation at the concentrations used in this study.
Effect of TCC on AR-mediated transcriptional activity
At a concentration of 1.0 m, TCC revealed little or no androgenicity when tested alone. In contrast, in the presence of a native androgen, such as T (0.125 nm), a 45% increase of the T-induced signal was observed (P Ͻ 0.05, Fig. 3 ) and this amplification of the T-induced transcriptional activity by TCC was both time dependent ( Fig. 4A ) and dose dependent (Fig. 4, B and C) . This amplification of the T-induced signal transcriptional activity was also detected in other urea compounds structurally similar to TCC (Fig. 5) . To further assess the mechanism by which TCC mediates the enhancement of the T signal, flutamide was used. This known antiandrogen functions as a competitive inhibitor for androgen binding to the AR (28) , and at 10 m, flutamide dramatically suppressed the amplification effect of 1.0 m TCC (P Ͻ 0.05, Fig. 3 ).
Competitive binding of TCC for AR
To investigate the potential of TCC to mimic the native hormone by binding to the AR, a competitive binding assay was conducted. As shown in Fig. 6 , TCC did not compete for T binding to the AR at tested concentrations up to 200 m. In contrast, the polarization value was reduced by 20 and 70% at DHT concentrations of 10 and 100 nm, respectively.
The effect of TCC treatment on AR protein
We investigated whether TCC increases the expression of the AR protein in cells that express endogenous AR. Western blot analysis indicated that, compared with vehicle control, an increase of immunoreactive AR protein was detected in MDA-kb2 cells treated with T or TϩTCC with the latter treatment yielding more AR protein (Fig. 7) . Similarly, T or TϩTCC combination treatment increased immunoreactive AR expression in 293 cells, compared with vehicle control; however, unlike the MDA-kb2 cells, there was no difference between the amount of protein observed in the TϩTCC combination treatment and the T-only treatment.
Effect of TCC on cAMP/PKA-mediated transcriptional activity
Numerous studies have indicated that AR-mediated signaling is affected by an array of cytokines and growth factors that act through a web of complex signaling cascades (29) . Of these, cAMP/PKA are particularly interesting because of the ability to phosphorylate AR in vivo and stimulate the expression of the AR-regulated gene expression (29 -31) . The concept of cAMP as an intracellular second messenger to a wide range of hormones, neurotransmitters, and other signaling substances is well developed (32) . The target for cAMP has been identified as cAMP-dependent protein kinase (PKA). In the absence of cAMP, PKA is an enzymatically inactive tetrameric holoenzyme (33) . To investigate TCC's potential to activate cAMP/PKA signaling, the ability of TCC to stimulate the transactivation of luciferase controlled by the cAMP/PKA pathway in a cAMP/PKA-mediated assay system was studied (27, 34) . As shown in Fig. 8 , TCC alone did not activate cAMP/PKA-mediated luciferase activity beyond control levels nor did it enhance the signal transduction induced by the presence of human CG (hCG), which is a strong stimulus for cAMP production in this system.
The effect of TCC treatment on organ weight after 10 d of treatment in castrated rats
To investigate TCC's potential amplification of native androgen ligands in vivo, we evaluated the effects of TCC in castrated male sd rats aged 48 -52 study the androgenic/antiandrogenic effects of AR ligands, EDS, and/or AR modulators on accessory sex tissues (35) . In this model, the change in the weight of accessory sex organs after various treatments is used to indicate the amount of androgenic support. TP (0.2 mg/kg) was used as the positive control due to its superior pharmacokinetic properties and enhanced efficacy both in humans and animal models (35) . A suboptimal dose of 0.2 mg/kg TP was selected for use to ensure the ability to observe an amplification effect of TCC.
No statistically significant differences were observed for total body or kidney weights between any groups; however, there was a slight increase in the mean liver weight in the group of animals treated with TCC alone (Table 1) . No significant differences were observed for the weights of the seminal vesicles, Cowper's gland, LABC muscle, and glans penis between sham-treated rats and rats receiving TCC only in the diet; however, an increase in ventral prostate weight was observed in rats treated with TCC only, compared with sham-treated rats. In contrast and as hypothesized, TP treatment alone significantly increased the weights of accessory sex organs, compared with controls and TCC alone ( Table 1 ).
The cotreatment of TP with TCC revealed a substantial and significant increase in the weights of all accessory sex organs, compared with TP treatment alone, indicating a synergism between TP and TCC in vivo (Table 1) .
Discussion
Recent reports relating to several nonsteroidal compounds indicate that a number of compounds have the ability to modulate, activate, and/or bind to the human AR (36) . These compounds are of particular public concern because human exposures to many of these compounds are ubiquitous and can accumulate in the environment, and human exposures to some of them are possibly constant (36, 37) . We therefore investigated the EDS properties of a subset of these compounds by using a cell-based AR-mediated reporting system (24) to determine whether any of these compounds are able to interfere with the natural action of endogenous androgens. In that investigation, most EDS were identified as weak antagonists (25) , but a small group of polychlorinated biphe- nyls were found to have enhancing properties and seemed worthy of further investigation. TCC is an antimicrobial agent commonly added to personal care products. The present data indicate that TCC has little or no androgenic activity alone but has an amplification effect on strong native androgens such as T. This amplification effect is characterized by an increased transcriptional activity transduced through the AR as the cotreatment of flutamide significantly suppressed the signal in vitro (Fig. 3) . It has been reported that 0.39% of an average 138 mg of triclocarban (or 0.54 mg) applied to the entire body was absorbed after a typical whole-body shower lather (38) . Therefore, the actual systemic dose of TCC would be approximately 0.1 mg/liter (or 0.1 g/ml) for an adult of 60 kg with 5 liters of blood. The concentration of TCC used in the in vitro study was 1.0 m, which is equal to approximately 0.3 g/ml. Thus, this in vitro dose represents only a 3-fold increase above that of a typical human exposure after a whole-body shower. Existing evidence also indicates that percutaneous penetration of similar compounds varies with the anatomic site of application. With chlorinated hydrocarbon pesticides, for example, the forearm allowed relatively less penetration, whereas the abdomen, scalp, and postauricular area and the scrotum allowed almost total absorption (39) .
One of the aims of the present study was to determine whether the in vitro endocrine disrupting effects of TCC could be supported in vivo. The use of 0.25% (wt/wt) TCC in the study was based on reports of extended TCC exposure in the rat (20) . Whereas many EDS seem to be less potent than the natural ligands in both in vitro and in vivo assays, comparable effects were observed when these compounds were administered at critical time points at doses that were several orders of magnitude lower (40) . Available data have demonstrated that TCC exposures by dermal or oral routes in rats and humans lead to similar metabolic profiles and that the administration of TCC in the diet is considered an appropriate way of assessing the toxicity of TCC (41) .
It is particularly noteworthy that in vivo, TCC in combination with TP resulted in a significant increase in accessory sex organ weights, compared with TP treatment alone, using the castrated male Sprague Dawley rat animal model (Table  1) . Our data strongly suggest that TCC has a positive AR modulatory effect in tissues or cells that are androgen targets. These observations open the possibility that other nuclear receptor signal transduction systems could also be modulated by TCC in a similar fashion. This possibility was confirmed in vitro by demonstrating that TCC also potentiated the estrogen receptor-␣-mediated signal transcriptional activity induced by estradiol as well as amplifying the cortisolinduced signal transduction in cells with endogenous expression of the glucocorticoid receptor (data not shown).
It should also be noted that the seminal vesicle, ventral prostate, and Cowper's gland weights increased additively with the TCC and T combination treatment. In contrast, only a marginal increase in the LABC muscle weight was observed with the combination treatment ( Table 1) . Further investigation will be required to determine whether TCC acts to preferentially enhance T's ability to increase reproductive organ weight over that of muscle mass.
The concentration of 1.0 m TCC tested in vitro was orders of magnitude in excess of the T concentration used. It is clear therefore that the relative binding efficiencies, if any, of TCC for the AR are orders of magnitude below that of the natural ligands. This conclusion is supported by the results of the AR competition assay in which TCC did not compete for T binding to the AR at concentrations up to 200 m (Fig. 6) . These results also support the concept that TCC is not a typical hormone mimic because it shows minimal receptor activation in the absence of cognate ligand (Fig. 3) .
Nuclear receptor-mediated signaling is affected by an array of cytokines and growth factors that act through a web of complex signaling cascades (32) . We found TCC alone did not activate cAMP/PKA-mediated luciferase activity nor did it enhance the signal transduction induced by hCG. These data indicate that the cAMP/PKA pathway may not be involved in the amplification of the T-induced transcriptional activity by TCC.
Recent evidence points to the potential role of MAPK pathways in the nuclear receptor mediated signal augmentation for certain EDS (21) . The prolonged half-life of the nuclear receptor, recruitment of novel coactivators, and involvement of a secondary binding domain in the nuclear receptor may also contribute to the signal potentiation phenomenon of TCC (42) (43) (44) (45) (46) . The synergistic increase of immunoreactive AR protein with TϩTCC treatment in MDA-kb2 cells, which express endogenous AR (Fig. 7) , could be the result of T and TCC on AR transcription and/or AR protein stability (43) . Whereas the synergistic effect of TCCϩT treatment on luciferase activity was observed in 2933Y cells, no synergistic effect on the amount of immunoreactive AR was detected. This lack of a pronounced increase of AR in the TϩTCC combination treatment in 2933Y cells could be due to the inherent differences between the exogenous AR in 2933Y cells and endogenous AR in MDA-kb2 cells (47) . Because much of the AR expression regulation is believed to occur at the posttranscriptional level, in which untranslated regions play a central role, the lack of both 5Ј-and 3Ј-untranslated regions in the exogenous AR transcripts in the 2933Y cells could result in different patterns of posttranscriptional gene regulation (47) . In addition, the synergistic effects of TϩTCC on AR-mediated transcriptional activity in 2933Y cells could arise from the altered DNA-binding activity of the receptor (48, 49) . Clearly, comprehensive investigations are required to identify the potential mechanisms of sex steroid amplification by TCC.
This report identifies a new category of EDS for androgens and other steroid hormones. The data presented here indicate that TCC and its urea analogs should be categorized as steroid hormone amplifiers or enhancers rather than simple agonists or antagonists because these compounds demonstrate the novel EDS property of synergism with the native androgen hormone receptor ligand (21) . To our knowledge, this is the first report regarding the synergistic effect of TCC on native sex hormones in vitro and in vivo. Given the scarcity of toxicological data in humans and laboratory animal models with respect to TCC and related compounds, the properties exhibited here by TCC may have more significance than for previously identified EDS. In terms of modulating steroid hormone action, TCC and its analogs elicit a positive biological effect rather than an inhibitory or weakly agonistic effect and have the potential to act through multiple nuclear receptors. This effect would be more likely to induce hyperstimulation rather than the attenuation of normal stimulation. Furthermore, the amplification effect of TCC on endogenous sex steroids may have an array of widespread subtle physiological alterations in both males and females. For example, because the amplification of androgens by TCC occurs at the target cell, there is the likelihood that such exposures may be associated with idiopathic hyperandrogenism. Thus, despite seemingly normal native circulating androgen levels, virilization may occur.
TCC exposure may also result in defects in development (i.e. cryptorchidism, hypospadias) or decreased reproductive function (decrease in sperm quality) in adults because compensation through the long-loop feedback would occur with the effect of lowering gonadotropin drive in response to TCC exposure. In females, increased androgenic feedback could disrupt the normal female-specific positive feedback loop associated with ovulation and derange ovarian function. The exposure to these EDS may also change the balance between estrogen signaling and androgen signaling in breast homeostasis. Depending on the level that hormone signaling pathways are disrupted (10, 50) , in utero exposure to TCC could also impair neurogenesis and sexually dimorphic neurobehavioral development. Because TCC has the potential to amplify synthetic steroidal compounds, further investigation of the interaction of TCC with oral contraceptives, hormone replacement therapy, synthetic androgens, and glucocorticoid therapy is also warranted. 
